The current valuation score of Prime Medicine Inc is 6.00, ranking 371 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.56, which is -72.13% below the recent high of -0.71 and -463.83% above the recent low of -14.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.